Human Albumin
BiologicalPatients received intravenous human albumin after gastric cancer surgery. Overall quantity of human albumin were recorded.
NCT Number: NCT04490668
We investigate whether the intravenously administered human albumin is beneficial to prevent anastomotic leakage after gastric cancer surgery.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Anastomotic leakage after gastric cancer surgery is not very common but it is a very critical postoperative complication. Anastomotic leakage severely compromises the recovery after surgery. It increases the overall burden of patients and hospital resources. Postoperative mortality is higher in patients with anastomotic leakage.
Human albumin is routinely administered after surgery with a unproven hypothesis that the human albumin is beneficial to prevent anastomotic leakage. We investigate whether the intravenously administered human albumin is beneficial to prevent anastomotic leakage after gastric cancer surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients received intravenous human albumin after gastric cancer surgery. Overall quantity of human albumin were recorded.
Time frame: Up to one months after the discharge of last patient
The rate of anastomotic leakage were compared among both groups
Ruijin Hospital
Other
Association of Human Albumin With Anastomotic Leakage After Gastric Cancer Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04292496
Anastomotic Leak, Digestive System Diseases
Nanchong, Sichuan, China
View Trial DetailsNCT06862479
Anastomotic Leak, Anastomotic Leak Esophagus
Lisbon, Lisbon District, Portugal
View Trial DetailsNCT05646290
Anastomotic Leak, Digestive System Diseases
Wuhan, Hubei, China
View Trial DetailsNCT06464978
Anastomotic Leak, Anastomotic Leakage
Nanchong, Sichuan, China
View Trial Details